Handbook on Injectable Drugs
9.1 12
v3.9.4 by Skyscape Medpresso Inc
About Handbook on Injectable Drugs
Handbook on Injectable Drugs (Package Name: com.medpresso.Lonestar.hbinjdrg) is developed by Skyscape Medpresso Inc and the latest version of Handbook on Injectable Drugs 3.9.4 was updated on June 3, 2024. Handbook on Injectable Drugs is in the category of Medical. You can check all apps from the developer of Handbook on Injectable Drugs and find 185 alternative apps to Handbook on Injectable Drugs on Android. Currently this app is for free. This app can be downloaded on Android 5.0+ on APKFab or Google Play. All APK/XAPK files on APKFab.com are original and 100% safe with fast download.
“Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.
For over 50 years American Society of Health-System Pharmacists is the most comprehensive reference on injectable drug data. 2024 edition features 400+ monographs on parenteral drugs, 24,500+ compatibility pairs, 3,700+ unique references
5-Star Rating from Doody's Review Service and Doody's Core Titles List Selection
ASHP® Injectable Drug Information™ 2024 content is interactive, mobile, and updated quarterly. Includes monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information..
Key Features
* Quick data search for 358 drugs
* 417 monographs on parenteral drugs available in the United States and in other countries
* Monographs cross-referenced with American Society of Health-System Pharmacists (AHFS) Drug Information through AHFS classification numbers
* More than 500 revisions to existing monographs (affecting 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2024.
* How to prepare, store and administer drugs
* Info accumulated from 3,603 references
* Drugs listed alphabetically by generic name for efficient searching, with brand names listed
WHAT'S NEW ASHP® Injectable Drug Information™ 2024 includes
* 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries.
* More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and other enhancements to the more than 24,100 compatibility pairs
* The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number.
* While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available.
Content licensed from printed edition ISBN 10: 1585286834
Content licensed from printed edition ISBN 13: 9781585286836
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $49.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Editor(s): ASHP
Publisher: American Society of Health-System Pharmacists
For over 50 years American Society of Health-System Pharmacists is the most comprehensive reference on injectable drug data. 2024 edition features 400+ monographs on parenteral drugs, 24,500+ compatibility pairs, 3,700+ unique references
5-Star Rating from Doody's Review Service and Doody's Core Titles List Selection
ASHP® Injectable Drug Information™ 2024 content is interactive, mobile, and updated quarterly. Includes monographs to Extended Stability for Parenteral Drugs, forming a single, comprehensive resource on injectable drug information..
Key Features
* Quick data search for 358 drugs
* 417 monographs on parenteral drugs available in the United States and in other countries
* Monographs cross-referenced with American Society of Health-System Pharmacists (AHFS) Drug Information through AHFS classification numbers
* More than 500 revisions to existing monographs (affecting 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and enhancements to the more than 24,100 compatibility pairs contained in ASHP® Injectable Drug Information™ 2024.
* How to prepare, store and administer drugs
* Info accumulated from 3,603 references
* Drugs listed alphabetically by generic name for efficient searching, with brand names listed
WHAT'S NEW ASHP® Injectable Drug Information™ 2024 includes
* 18 new monographs, bringing the total in this edition to 417 monographs on parenteral drugs available in the United States and in other countries.
* More than 500 revisions to existing monographs (affecting nearly 60% of the existing monographs) have been accomplished to update information on stability, compatibility, and safety (e.g., Food and Drug Administration [FDA] MedWatch alerts) and to provide more specific referencing of manufacturer information and other enhancements to the more than 24,100 compatibility pairs
* The information cited throughout the text has been compiled from 3603 references, including 195 new to this edition. Because information from pharmaceutical manufacturers had not been uniquely cited until the 18th edition, the number of unique references supporting ASHP® Injectable Drug Information™ 2024 information actually greatly exceeds this number.
* While primary, peer-reviewed literature remains a major source of compatibility and stability information, ongoing efforts are underway to provide increased specificity of references to the pharmaceutics research of drug manufacturers. Other relevant information and pertinent study details supplied by corresponding authors of the published literature also have been incorporated when available.
Content licensed from printed edition ISBN 10: 1585286834
Content licensed from printed edition ISBN 13: 9781585286836
SUBSCRIPTION :
Please purchase a yearly auto-renewing subscription to receive content access and available updates.
Yearly auto-renewing payments- $49.99
Payment will be charged to your iTunes Account at confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24-hours before the end of the current period. Subscription may be managed by the user and auto-renewal can be disabled at any time by going to your device “Settings” and tapping “iTunes & App Store”. Any unused portion of a free trial period will be forfeited when you purchase a subscription, where applicable.
If you have any questions or comments, email us any time: customersupport@skyscape.com or call 508-299-30000
Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx
Editor(s): ASHP
Publisher: American Society of Health-System Pharmacists
Read More
Handbook on Injectable Drugs Features
Previous Versions
More
Requires Android: Android 5.0+
Architecture: arm64-v8a, armeabi-v7a, x86, x86_64
Screen DPI: 120-640dpi
SHA1: 82e7339fdaaa35b28e3fbdd8660f7e110933440a
Size: 12.22 MB
Variant
Arch
Version
DPI
31
June 2, 2024
Handbook on Injectable Drugs
3.9.4
(31)
Requires Android: Android 5.0+
Architecture: arm64-v8a
Screen DPI: 160-640dpi
SHA1: f39632432ac4019694aec69cfa171e87b1753eea
Base APK: com.medpresso.Lonestar.hbinjdrg.apk
Split APKs: config.arm64_v8a, config.xxhdpi
Size: 7.7 MB
arm64-v8a
Android 5.0+
160-640dpi
31
June 3, 2024
Handbook on Injectable Drugs
3.9.4
(31)
Requires Android: Android 5.0+
Architecture: armeabi-v7a
Screen DPI: 160-640dpi
SHA1: 3c013130a68d4f6a4130b4bd8a0b59c938a1b934
Base APK: com.medpresso.Lonestar.hbinjdrg.apk
Split APKs: config.armeabi_v7a, config.xhdpi
Size: 7.57 MB
armeabi-v7a
Android 5.0+
160-640dpi
31
June 3, 2024
Handbook on Injectable Drugs
3.9.4
(31)
Requires Android: Android 5.0+
Architecture: arm64-v8a
Screen DPI: 160-640dpi
SHA1: f763846bc3a744c44a7fb3080130dafa94c90123
Base APK: com.medpresso.Lonestar.hbinjdrg.apk
Split APKs: config.arm64_v8a, config.xxxhdpi
Size: 7.83 MB
arm64-v8a
Android 5.0+
160-640dpi
Requires Android: Android 5.0+
Architecture: arm64-v8a, armeabi-v7a, x86, x86_64
Screen DPI: 120-640dpi
SHA1: e6bfc097672b118755beb3d4cf98fa84208143c1
Size: 12.24 MB
What's New:
- Keep your app updated to get the latest experience on your Android phones & tablets
- We want you to get notified about exclusive offers, promotions, & discounts. This updates does this directly through in-app notifications
- We have also updated our billing system with the latest Google Billing Library to ensure smoother and more secure transactions.
- Our app is now compatible with Android 13, ensuring compatibility with the latest features and improvements offered by the Android platform.
- We want you to get notified about exclusive offers, promotions, & discounts. This updates does this directly through in-app notifications
- We have also updated our billing system with the latest Google Billing Library to ensure smoother and more secure transactions.
- Our app is now compatible with Android 13, ensuring compatibility with the latest features and improvements offered by the Android platform.
Requires Android: Android 5.0+
Screen DPI: 120-640dpi
SHA1: bf07b80ae6435dc1824013ee2fbbd1ac1aadb5b9
Size: 12.05 MB
More Information
Package Name:
Update Date:
2024-06-03
Latest Version:
3.9.4
Need Update:
Available on:
Requirements:
Android 5.0+
Report:
Safe to Download
APKFab.com and the download link of this app are 100% safe. All download links of apps listed on APKFab.com are from Google Play Store or submitted by users. For the app from Google Play Store, APKFab.com won't modify it in any way. For the app submitted by users, APKFab.com will verify its APK signature safety before release it on our website.